NRG Oncology Virtual Summer Meeting - July 16-18, 2020

 

Summer2020VirtualLogo


Meeting Slides


General Session

Full session slides

NRG Town Hall

Full session slides

NCORP Sessions

NRG NCORP Town Hall

NRG Cancer Prevention & Control

NRG Cancer Care Delivery Research

Genitourinary Cancer Committee

Introduction

NRG GU Workshop

NRG-GU002 

NRG-GU005

NRG-GU006

NRG-GU007

NRG-GU008

NRG-GU009

RTOG 3506

AE8143 - PROSPER RCC

ECOG NRG 8185

SWOG NRG 1806 

Gastrointestinal Cancer Committee - Non-Colorectal 

Introduction

Non-CRC 

Lung Cancer Committee

Introduction 

Investigator Resources

NRG-CC003

NRG-CC009

NRG-LU002

NRG-LU003

NRG-LU004

NRG-LU005

NRG-LU006

NRG-LU007

RTOG 1308

RTOG 3515

S1914

LungMAP

ALCHEMIST

Head and Neck Cancer Committee

Introduction

Head and Neck Cancer Workshop

NRG-HN001

NRG-HN004

NRG-HN005

NRG-HN006

NRG-HN007

NRG-HN008

NRG-HN1936

NRG-HN1937

NRG-HN2001

NRG-HN2004

RTOG 1008

RTOG 1216

RTOG 3507

EA3132

EA3163, EA3161

Head and Neck Cancer Publications

Head and Neck Steering Committee

Head and Neck Cancer Biospecimen Access

Head and Neck Cancer Investigator Resources

NCI COVID-19 Overview

Brain Tumor Committee

Introduction

Portfolio and Investigator Resources

NRG-BN2028

A Phase II Prospective Randomized Clinical Trial of Time, Dose, Fractionation, and Sequence of SRS and Immunotherapy in Melanoma Patients with Brain Metastases

Randomized Phase II/III Clinical and Translational Trial of Combination Checkpoint and IDO1 Inhibition with Chemoradiotherapy/Radiotherapy for Newly Diagnosed Glioblastoma

A Multi-site, Cooperative Group Study Establishing Quality and Feasibility of Multiparametric MRI for Radiation Tumor Targeting in Glioblastoma (Lead-in to a Randomized Phase III Trial)

Phase 1/2 Study of Mebendazole plus Radiation in Patients with Recurrent Meningioma Grade 2 or 3

PRIDE: Phase I/II study of Radiation /Temozolomide and Immunotherapy with  Daratumumab to improve antitumor Efficacy in newly diagnosed Glioblastoma 

Phase II Trial: Adenoviral Vectors Expressing FLT3L and HSV1-TK for Newly Diagnosed Resectable Malignant Glioma

EORTC 1634-BTG

Protocol Support Committee - CTN & CRA Workshop Educational Sessions-Thurs, July 16, 2020
Click here for slide sets/handouts for these presentations (login req'd)

Health Disparities Committee

HDC Overview
Life Cycle of a Health Disparities Researcher

NRG New Investigators Educational Session (held Monday, July 20, 2020)

Webinar Slides

Webinar Recording
Please skip to 4:15 of the recording where the webinar begins.

Thank you to all for your participation in the 1st NRG Oncology Virtual Summer Meeting!

Program Book

Main Agenda

Session Flyers & Promotional Materials

NRG Oncology Townhall

General Session

CTN/CRA Workshop Educational Programs

FORTE Workshop

Digital Health Symposium

NCORP Townhall

Other Materials and Information

FORTE Study Brochure

Gyn Concepts

Policies 

NRG Oncology Anti-Harassment Statement

NRG Oncology Meetings Code of Conduct Policy

Questions?

Contact us at meeting-reg@nrgoncology.org if you have any questions or require more information.


Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.